News

Pharmabiz22m
Merck announces 2025 Merck Young Scientist Award
Our Bureau, Bengaluru Wednesday, July 2, 2025, 16:15 Hrs [IST] Merck is back with its fourth edition of the Merck Young Scientist ...
Pharmabiz37m
Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine
Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine: Cambridge, Massachusetts Wednesday, July 2, 2025, 16:00 Hrs [IST] Moderna, Inc ...
Pharmabiz52m
CarePay launches intelligent assistant AI-powered healthcare EMI platform Careena
CarePay launches intelligent assistant AI-powered healthcare EMI platform Careena: Our Bureau, Bengaluru Wednesday, July 2, 2025, 15:45 Hrs [IST] CarePay, India's pioneering finte ...
Pharmabiz1h
Nymi and Caliber Technologies ink pact to enable passwordless authentication in pharma manufacturing
Nymi and Caliber Technologies ink pact to enable passwordless authentication in pharma manufacturing: Our Bureau, Bengaluru Wednesday, July 2, 2025, 15:30 Hrs [IST] Nymi, an Innom ...
Pharmabiz1h
AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country
AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country: Our Bureau, Bengaluru Wednesday, July 2, 2025, 15:15 Hrs [IST] AstraZeneca Pharma Indi ...
Pharmabiz1h
US FDA clears Iksuda Therapeutics’ IND application for IKS014
US FDA clears Iksuda Therapeutics’ IND application for IKS014: New Castle, England Wednesday, July 2, 2025, 15:00 Hrs [IST] Iksuda Therapeutics, a clinical stage and UK-based bi ...
Pharmabiz2h
Repronovo announces first participant included in US phase 2 trial of RPN-001 to treat MALE INFERTILITY
Repronovo announces first participant included in US phase 2 trial of RPN-001 to treat MALE INFERTILITY: Lausanne, Switzerland Wednesday, July 2, 2025, 14:00 Hrs [IST] ReproNovo, ...
Pharmabiz3h
NIH study shows breast cancer risk in younger women may be influenced by hormone therapy
NIH study shows breast cancer risk in younger women may be influenced by hormone therapy: Bethesda, Maryland Wednesday, July 2, 2025, 13:00 Hrs [IST] Scientists at the National In ...
Pharmabiz4h
Lupin receives US FDA approval for loteprednol etabonate ophthalmic gel
Lupin receives US FDA approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Wednesday, July 2, 2025, 11:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...
Pharmabiz5h
Karnataka govt informs DCGI to probe into 'unfair clinical trials' at HCG
Karnataka govt informs DCGI to probe into 'unfair clinical trials' at HCG: Our Bureau, Bengaluru Wednesday, July 2, 2025, 11:10 Hrs [IST] Karnataka government has written to the D ...
Pharmabiz5h
WuXi XDC announces the mechanical completion of its Singapore site, accelerating the global expansion of bioconjugates manufacturing
WuXi XDC announces the mechanical completion of its Singapore site, accelerating the global expansion of bioconjugates manufacturing: Shanghai, China Wednesday, July 2, 2025, 11:0 ...
Pharmabiz6h
atai Life Sciences & Beckley Psytech announce positive results from phase 2b study of BPL-003 in patients with treatment-resistant depression
Life Sciences & Beckley Psytech announce positive results from phase 2b study of BPL-003 in patients with treatment-resistant depression: New York Wednesday, July 2, 2025, 10 ...